Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Medri

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Medical Case Reports|April 10, 2022
Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case reportCesare Medri, Adriana Méndez, Angelika Hammerer-Lercher, et al.
Annals of Hematology|February 16, 2021
The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature reviewLinet Njue, Cesare Medri, Peter Keller, et al.
Journal of Clinical Medicine|June 2, 2021
Platelet Transfusion-Insights from Current Practice to Future DevelopmentAnnina Capraru, Katarzyna Aleksandra Jalowiec, Cesare Medri, et al.
Journal of Clinical Medicine|July 27, 2022
Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress<sup>®</sup> 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical PracticeAlicia Rovó, Claudia Baierlein-Leimbach, Cesare Medri, et al.
The Lancet. Rheumatology|September 13, 2021
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label studyMatthias B Moor, Franziska Suter-Riniker, Michael P Horn, et al.
RMD Open|April 1, 2022
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapyDaniel Sidler, Alexander Born, Simeon Schietzel, et al.
Plos One|March 26, 2026
Plasma heme pool compartmentalization is linked to pathophysiology in Sickle Cell DiseaseMoritz Saxenhofer, Daniel Couto, Sandra Mena Perez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Medical Case Reports|April 10, 2022
Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case reportCesare Medri, Adriana Méndez, Angelika Hammerer-Lercher, et al.
Annals of Hematology|February 16, 2021
The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature reviewLinet Njue, Cesare Medri, Peter Keller, et al.
Journal of Clinical Medicine|June 2, 2021
Platelet Transfusion-Insights from Current Practice to Future DevelopmentAnnina Capraru, Katarzyna Aleksandra Jalowiec, Cesare Medri, et al.
Journal of Clinical Medicine|July 27, 2022
Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress<sup>®</sup> 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical PracticeAlicia Rovó, Claudia Baierlein-Leimbach, Cesare Medri, et al.
The Lancet. Rheumatology|September 13, 2021
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label studyMatthias B Moor, Franziska Suter-Riniker, Michael P Horn, et al.
RMD Open|April 1, 2022
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapyDaniel Sidler, Alexander Born, Simeon Schietzel, et al.
Plos One|March 26, 2026
Plasma heme pool compartmentalization is linked to pathophysiology in Sickle Cell DiseaseMoritz Saxenhofer, Daniel Couto, Sandra Mena Perez, et al.
Pageof 1